Market research
LBT.AU LBT Innovations Limited
AU AUD Healthcare
Latest close
As of 04 Feb 2025
Test a moving-average rule with historical data.
Market facts
- Market cap
- 30M
- P/E ratio
- Not available
- Analyst target
- 0.2
- Dividend yield
- Not available
- Beta
- 1.69
Profile
Instrument facts
- Exchange
- AU
- Currency
- AUD
- Sector
- Healthcare
- Industry
- Medical Devices
- ISIN
- AU0000367153
- Market cap
- 30M
- P/E ratio
- Not available
- Analyst target
- 0.2
- Dividend yield
- Not available
- Beta
- 1.69
About
About LBT Innovations Limited
Clever Culture Systems Limited engages in the research, development, and commercialization of technology solutions for medical industry in Australia, the United States, Sweden, the United Kingdom, and Germany. The company offers Automated Plate Assessment System (APAS) Independence, a solution that automates the imaging, analysis, and interpretation of microbiology culture plates primarily for microbiology laboratories and pharmaceutical manufacturing sector; APAS Analysis Modules, a software algorithm that enables the screening of microbiology culture plates collected during environmental monitoring; and APAS PharmaQC, an artificial intelligence for culture plate reading. It also develops APAS intelligent imaging technology for various applications, which includes wound treatment, histopathology, and antimicrobial susceptibility testing. The company was formerly known as LBT Innovations Limited and changed its name to Clever Culture Systems Limited in November 2024. Clever Culture Systems Limited was incorporated in 2004 and is headquartered in Adelaide, Australia.
Research context
LBT Innovations Limited appears in PyInvesting’s Australia Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- AUD
- Sector
- Healthcare
- Industry
- Medical Devices
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
Community
Investor discussion
1 comment
Sign in to join the LBT.AU discussion.
5 years, 6 months ago
LBT Innovations Limited is currently in a long term downtrend where the price is trading 16.4% below its 200 day moving average.
From a valuation standpoint, the stock is 91.3% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 22.4.
LBT Innovations Limited's total revenue rose by 3.1% to $786K since the same quarter in the previous year.
Its net income has dropped by 5.3% to $-3M since the same quarter in the previous year.
Finally, its free cash flow grew by 29.8% to $-785K since the same quarter in the previous year.
Based on the above factors, LBT Innovations Limited gets an overall score of 3/5.